Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EVE Health Group Limited ( (AU:EVE) ) just unveiled an announcement.
EVE Health Group reported a 19% decrease in revenue from ordinary activities for the financial year ending June 30, 2025, compared to the previous year. The company also saw a 17% reduction in net loss attributable to members, with no dividends declared during the period. Despite the financial downturn, EVE Health Group continues to focus on its core operations in the health sector, aiming to strengthen its market position through its subsidiaries.
More about EVE Health Group Limited
EVE Health Group (ASX: EVE) is an Australian-based health company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.
Average Trading Volume: 486,375
Technical Sentiment Signal: Sell
Current Market Cap: A$7.88M
See more insights into EVE stock on TipRanks’ Stock Analysis page.